BPC
PFE icon

Bearing Point Capital’s Pfizer PFE Stock Holding History

Bearing Point Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$753K Sell
26,829
-333
-1% -$8.87K 0.12% 108
2025
Q4 		$676K Sell
27,162
-18,937
-41% -$478K 0.11% 120
2025
Q3 		$1.17M Sell
46,099
-550
-1% -$13.6K 0.2% 85
2025
Q2 		$1.13M Sell
46,649
-5,491
-11% -$128K 0.21% 85
2025
Q1 		$1.32M Buy
52,140
+2,690
+5% +$70.4K 0.28% 78
2024
Q4 		$1.31M Buy
+49,450
New +$1.34M 0.27% 80

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bearing Point Capital's PFE Position: Q1 2026 in Review

Bearing Point Capital reduced its Pfizer (PFE) stake by 1.2% in Q1 2026, selling an estimated $8.87K and leaving 26,829 shares worth $753K. The position accounts for 0.12% of the portfolio, ranked #108.

Bearing Point Capital first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.32M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bearing Point Capital held 26,829 shares of Pfizer worth $753K as of Q1 2026.
  • Bearing Point Capital sold 333 Pfizer shares in Q1 2026, an estimated $8.87K.
  • Pfizer made up 0.12% of Bearing Point Capital's portfolio in Q1 2026, its #108 holding.
  • Bearing Point Capital first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Bearing Point Capital's Pfizer position peaked at $1.32M in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bearing Point Capital's 13F filing for Q1 2026, filed 7 May 2026.